REVANCE THERAPEUTICS, INC.
ent_019e229ff4a42c3a9d0ae8410bd66f69
Disclosures
6
State AG · 5 jurisdictions
Multi-filing incidents
1
incidents joining 2+ filings here
Max affected reported
2,803
nationwide · State AG IN
Leak-site claims
0
none in sample
Identity resolution
- Canonical name
- REVANCE THERAPEUTICS, INC.
- Normalized
- revance therapeutics— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- 549300N33TFDZHS81H11
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- None on record
Disclosure history (6)newest first
- Montana State AGas victim2023-07-10
Revance Therapeutics, Inc. notified individuals of a data breach where an unauthorized third party accessed and exfiltrated personal information (names, SSNs, DOBs, driver's licenses) from March 15 to April 10, 2023. The breach was discovered on April 9, 2023. Revance terminated access, engaged forensic specialists, notified law enforcement, and offered two years of identity monitoring via Kroll.
- Indiana State AGas victim2023-07-10
Revance Therapeutics, Inc reported a data breach to the Indiana Attorney General. The breach occurred on 2023-03-15 and was reported on 2023-07-10. 8 Indiana residents were affected. 2,803 individuals affected in total.
- Maine State AGas victim2023-07-10
On April 9, 2023, Revance Therapeutics, Inc. discovered that an unauthorized third party had accessed its systems between March 15, 2023, and April 10, 2023, by compromising an employee's credentials. The investigation, completed on June 15, 2023, confirmed that personal information, including financial account details, was exfiltrated. The company has since enhanced its security controls, notified law enforcement, and offered 24 months of identity monitoring services to affected individuals.
- Maine State AGas victim2023-07-10
Revance Therapeutics, Inc. reported a data breach affecting 2,803 individuals after an unauthorized third party accessed company systems using compromised employee credentials between March 15, 2023, and April 10, 2023. The breach was discovered on April 9, 2023. The compromised information included names and financial account numbers with access codes. In response, Revance engaged a cybersecurity firm, notified law enforcement, and offered 24 months of identity monitoring services to affected individuals. The company has since enhanced its identity access and authentication controls.
- California State AGas victim2023-07-10
Revance Therapeutics, Inc. disclosed that an unauthorized third party accessed and exfiltrated personal information from its systems between March 15, 2023, and April 10, 2023. The company discovered the incident on April 9, 2023. Affected data includes names and other personal information. Revance terminated the attacker's access, engaged cybersecurity specialists, notified law enforcement, and offered two years of identity monitoring through Kroll.
- Massachusetts State AGas victim2023-07-10
Revance Therapeutics, Inc. reported a data breach to the Massachusetts Office of Consumer Affairs and Business Regulation. The breach was reported on 2023-07-10. 15 Massachusetts residents were affected. The report records the breach type as electronic.